EP3046536
Bættar eitlaveirusamsetningar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.9.2014EP published:
28.11.2018EP application number:
14766474.2
EP translation filed:
11.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
15.9.2034Expiry date:
15.9.2023
Title:
IMPROVED ADENOVIRUS FORMULATIONS
Timeline
Today
16.9.2014EP application
28.11.2018EP Publication
11.2.2019Translation submitted
15.3.2019Registration published
15.9.2023Expires
Owner
Name:
Janssen Vaccines & Prevention B.V.Address:
Archimedesweg 4, 2333, CN Leiden, NL
Inventor
Name:
ADRIAANSEN, JanikAddress:
NL-2333 CN Leiden, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13185200Date:
19.9.2013Country:
EP
Classification
Categories:
A61K 9/00, A61K 47/02, A61K 47/10, A61K 47/12, A61K 47/18, A61K 47/26, A61K 9/08, A61K 47/40, A61K 35/76, C12N 15/86
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 7.8.2019
Expires: 15.9.2020
Payer: Árnason Faktor
Number: 7
Paid: 6.8.2020
Expires: 15.9.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.8.2021
Expires: 15.9.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 16.8.2022
Expires: 15.9.2023
Payer: Árnason Faktor ehf.